相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative analysis of cell surface antigen-antibody interaction using Gaussia princeps luciferase antibody fusion proteins
Juliane Kums et al.
MABS (2017)
Denosumab: Current Use in the Treatment of Primary Bone Tumors
Olga D. Savvidodou et al.
ORTHOPEDICS (2017)
Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells
Isabell Lang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
Martin Chopra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Principles of antibody-mediated TNF receptor activation
H. Wajant
CELL DEATH AND DIFFERENTIATION (2015)
Denosumab in osteoporosis
Dima L. Diab et al.
EXPERT OPINION ON DRUG SAFETY (2014)
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo
Johannes Trebing et al.
MABS (2014)
CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants
J. Trebing et al.
CELL DEATH & DISEASE (2014)
TNF receptor-associated factor 1 is a major target of soluble TWEAK
Jose Antonio Carmona Arana et al.
FRONTIERS IN IMMUNOLOGY (2014)
Engineering death receptor ligands for cancer therapy
Harald Wajant et al.
CANCER LETTERS (2013)
Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
Steffen Salzmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo
Fubin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
Bharat B. Aggarwal et al.
BLOOD (2012)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency
M. Chodorge et al.
CELL DEATH AND DIFFERENTIATION (2012)
Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fcγ receptor engagement
Fubin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
Nicholas S. Wilson et al.
CANCER CELL (2011)
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
Sang Taek Jung et al.
CURRENT OPINION IN BIOTECHNOLOGY (2011)
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Ann L. White et al.
JOURNAL OF IMMUNOLOGY (2011)
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
Fubin Li et al.
SCIENCE (2011)
Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)
Hilka Rauert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways
Daniela Berg et al.
FEBS JOURNAL (2009)
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
Agnes Wyzgol et al.
JOURNAL OF IMMUNOLOGY (2009)
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization
Nicole Mueller et al.
FEBS JOURNAL (2008)
Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity
Anja Krippner-Heidenreich et al.
JOURNAL OF IMMUNOLOGY (2008)
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L
D. Berg et al.
CELL DEATH AND DIFFERENTIATION (2007)
Three is better than one: Pre-ligand receptor assembly in the regulation of TNF receptor signaling
Francis Ka-Ming Chan
CYTOKINE (2007)
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
F Henkler et al.
JOURNAL OF CELL BIOLOGY (2005)
FcγRs modulate cytotoxicity of anti-fas antibodies:: Implications for agonistic antibody-based therapeutics
YY Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Anti-CD95-induced lethality requires radioresistant FcγRII+ cells -: A novel mechanism for fulminant hepatic failure
S Jodo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Actin cytoskeleton is required for early apoptosis signaling induced by anti-Fas antibody but not Fas ligand in murine B lymphoma A20 cells
M Bando et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
RJ Ober et al.
INTERNATIONAL IMMUNOLOGY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
分享论文
